Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway.
作者信息
Li Wan, Yi Jie, Zheng Xiangjin, Liu Shiwei, Fu Weiqi, Ren Liwen, Li Li, Hoon Dave S B, Wang Jinhua, Du Guanhua
机构信息
The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.
出版信息
Clin Epigenetics. 2024 Dec 27;16(1):191. doi: 10.1186/s13148-024-01797-6.
Abstract
摘要
Zotero 插件